Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study
A randomized, open-label comparative study of entecavir versus adefovir therapy was performed in subjects with chronic hepatitis B who had hepatic decompensation (Child-Turcotte-Pugh score ≥7). Adult subjects were randomized and treated (n = 191) with entecavir 1.0 mg or adefovir 10 mg daily for up...
Saved in:
Main Authors: | Yun Fan Liaw, Maria Raptopoulou-Gigi, Hugo Cheinquer, Shiv Kumar Sarin, Tawesak Tanwandee, Nancy Leung, Cheng Yuan Peng, Robert P. Myers, Robert S. Brown, Lennox Jeffers, Naoky Tsai, Jolanta Bialkowska, Shijie Tang, Suzanne Beebe, Elizabeth Cooney |
---|---|
Other Authors: | Chang Gung University College of Medicine |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/12463 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
by: Marcellin, P., et al.
Published: (2014) -
Treatment of hepatitis B e antigen-positive chronic hepatitis with telbivudine or adefovir: A randomized trial
by: Chan, H.L.Y., et al.
Published: (2016) -
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
by: Hadziyannis, S.J., et al.
Published: (2014) -
Lamivudine Switching after Undetectable HBV DNA is Associated with High Rate of Virological Rebound in Entecavir-treated Chronic Hepatitis B Patients
by: S. Chainuvati, et al.
Published: (2020) -
Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
by: Marcellin, P., et al.
Published: (2016)